Table 1 Clinical features, treatments and prognosis in four cases of MEITL
| Â | Case 1 | Case 2 | Case 3 | Case 4 |
|---|---|---|---|---|
Age (years) | 60 | 40 | 50 | 70 |
Sex | M | F | F | M |
Chief complaints | Diarrhea | Diarrhea | Abdominal distention | Nausea |
Duration of chief complains (mons) | 17 | 3 | 1 | 2 |
Total protein (g/dl) | 4 | 4.4 | 6.6 | 6.4 |
Albumin (g/dl) | 2.1 | 2.9 | 3.8 | 3 |
LDH (IU/l) | 165 | 156 | 187 | 150 |
sIL2R (U/ml) | 963 | 1419 | 4150 | 587 |
Anti-gliadin/-transglutaminase tests | −/− | ne | ne | ne |
Helicobacter pylori IgG antibody | − | ne | − | + |
Gastrointestinal perforation | − | + (after treatment) | − | − |
Bone marrow tumour invasion | + (30 %) | − | + (30 %) | + (20 %) |
Clinical stage | IV | I | IV | IV |
Treatment (regimen) | CHASE, SCT | THP-COP, surgery | CHOP, SCT | SMILE |
Response | Partial response | No response | Partial response | Partial response |
Survival times (months) | 36, dead | 12, dead | 9, dead | 9, dead |